How people over 65 understand their long-term medicines
Understanding Chronic Treatments by Patients Over 65 Years of Age
This project will see how well people aged 65 and older understand the chronic medications prescribed to them by their general practitioner.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 150 (estimated) |
| Ages | 65 Years and up |
| Sex | All |
| Sponsor | Université de Reims Champagne-Ardenne Academic / other |
| Locations | 2 sites (Reims, Université de Reims Champagne-Ardenne and 1 other locations) |
| Trial ID | NCT07241299 on ClinicalTrials.gov |
What this trial studies
This is an observational study enrolling patients aged 65 or over who consult participating general practitioners in Reims and who have at least one prescription for a treatment intended to last more than three months. Data are collected during GP consultations about patients' knowledge of their medications and related factors such as number of drugs, communication with the prescriber, and sociodemographic information. The primary goal is to describe the level of understanding of chronic treatments in this population, and secondary analyses will identify factors associated with better or worse understanding. No experimental intervention is given; results will be used to inform primary care practices and potential future interventions to improve medication understanding and adherence.
Who should consider this trial
Good fit: Ideal candidates are French-speaking adults aged 65 or older who visit a participating general practitioner and have at least one prescription for a medication intended to be used for more than three months, and who do not have neurocognitive disorders or legal guardianship.
Not a fit: Patients who are non–French-speaking, have diagnosed neurocognitive disorders, live in medical/residential care facilities, are under legal protection (guardianship/curatorship), or are consulting only for acute conditions without chronic prescriptions are unlikely to benefit from participating.
Why it matters
Potential benefit: If successful, the findings could help general practitioners improve how they explain long-term medications, reducing errors and nonadherence among older patients.
How similar studies have performed: Previous observational studies have repeatedly documented limited understanding and adherence to medications among older adults, so this study builds on established findings rather than testing a novel treatment.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Are aged 65 or over * Consulting one of the general practitioners agreeing to participate in the study * Have a prescription containing at least one chronic treatment (defined as a treatment lasting more than 3 months) * Agree to participate in the study. Exclusion Criteria: * Does not understand French, * Has neurocognitive disorders * Lives in a medical facility * Consulting for an acute condition and whose prescription does not include chronic treatment. * Protected by law (guardianship, curatorship, judicial protection),
Where this trial is running
Reims, Université de Reims Champagne-Ardenne and 1 other locations
- Gestonnairedu CURRS — Reims, Université de Reims Champagne-Ardenne, France (Recruiting)
- Ufr Medecine Urca — Reims, France (Recruiting)
Study contacts
- Study coordinator: Gestonnairedu CURRS
- Email: currs@univ-reims.fr
- Phone: 0326918822
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.